Jaundice treatment thresholds for very premature babies
Part of Genetic & congenital clinical trials.
This study looks at how hospitals decide when to start treatment for jaundice (a yellowing of the skin) in very premature babies. The aim is to find the safest and most effective way to use bilirubin levels to guide care and improve outcomes for your baby.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby must have been born before 30 weeks of pregnancy.
- Your baby must be admitted to a participating NICU within 24 hours after birth.
- You must give permission for your baby to take part, following the approved consent process.
- Your baby must not have major birth defects that could affect survival or brain development.
- Your baby must not have a prenatally diagnosed immune hemolytic disease (like Rh disease) that needs special treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a device that measures jaundice level through the skin without needing a blood test. It is for newborns who need light therapy.
This study is looking at a new scoring system to help doctors quickly tell how severe jaundice is in newborns. The goal is to better decide when a baby needs stronger treatment like a blood exchange, so the right care can be given sooner.
This trial tests different ways to give light therapy to newborns with jaundice. It compares different approaches to see which is best, and may help parents understand the most effective treatment for their baby.
This study looks for a safe threshold to stop the “light therapy” (phototherapy) in newborns who have jaundice caused by blood cell breakdown (hemolytic disease). It may help some babies avoid unnecessary extra days of treatment while still staying safe.
This study tests whether gentle foot reflexology and massage can help newborns with jaundice (high bilirubin levels in the blood) recover faster during light therapy treatment. Jaundice is common in newborns and is usually treated with special lights; this trial explores whether touch therapy might improve outcomes.
This study looks at what happens to a newborn's bilirubin level (the substance that causes jaundice) in the 48 hours after light therapy (phototherapy) is stopped, to see if it goes back up. It aims to help predict which babies might need more treatment.
Hear when a new Neonatal Hyperbilirubinemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.